Stavudine 200mg + Lamivudine 150mg + Nevirapine 30mg
This antiretroviral formulation combines two nucleoside reverse transcriptase inhibitors with a non-nucleoside reverse transcriptase inhibitor, designed for use in specific clinical settings for the management of HIV-1 infection, in line with applicable treatment protocols.
Product Details
Therapeutic Class
Nucleoside Reverse Transcriptase Inhibitors (Stavudine + Lamivudine)
Non-Nucleoside Reverse Transcriptase Inhibitor (Nevirapine)
Indication
Treatment of HIV-1 infection in adults and pediatric patients as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations and national treatment policies.
Dosage & Administration
To be administered as per recommended dosing schedules based on patient age, body weight, and clinical condition, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets
Stavudine 200mg + Lamivudine 150mg + Nevirapine 30mg
This antiretroviral formulation combines two nucleoside reverse transcriptase inhibitors with a non-nucleoside reverse transcriptase inhibitor, designed for use in specific clinical settings for the management of HIV-1 infection, in line with applicable treatment protocols.
Product Details
Therapeutic Class
Nucleoside Reverse Transcriptase Inhibitors (Stavudine + Lamivudine)
Non-Nucleoside Reverse Transcriptase Inhibitor (Nevirapine)
Indication
Treatment of HIV-1 infection in adults and pediatric patients as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations and national treatment policies.
Dosage & Administration
To be administered as per recommended dosing schedules based on patient age, body weight, and clinical condition, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets
Stavudine 200mg + Lamivudine 150mg + Nevirapine 30mg
This antiretroviral formulation combines two nucleoside reverse transcriptase inhibitors with a non-nucleoside reverse transcriptase inhibitor, designed for use in specific clinical settings for the management of HIV-1 infection, in line with applicable treatment protocols.
Product Details
Therapeutic Class
Nucleoside Reverse Transcriptase Inhibitors (Stavudine + Lamivudine)
Non-Nucleoside Reverse Transcriptase Inhibitor (Nevirapine)
Indication
Treatment of HIV-1 infection in adults and pediatric patients as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations and national treatment policies.
Dosage & Administration
To be administered as per recommended dosing schedules based on patient age, body weight, and clinical condition, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets